Clinical Trials in Litchfield Park, Arizona

Find clinical trials in Litchfield Park, Arizona. Discover local research opportunities and treatment options in your area.

8 Active Trials Found in Litchfield Park

Showing 8 trials on this page

Page 1 of 1

A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)

NCT ID: NCT03519945

The LUCENT 3 clinical trial is studying a medication called mirikizumab to see how effective and safe it is for treating people with moderately to severely active ulcerative colitis (UC) over a lon...

Recruiting

Phase: PHASE3 Conditions: Ulcerative Colitis

A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)

NCT ID: NCT06052059

This clinical trial is studying a new medication called tulisokibart (MK-7240) to see if it is effective and safe for people with moderately to severely active ulcerative colitis, a condition that ...

Recruiting

Phase: PHASE3 Conditions: Ulcerative Colitis

A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden

NCT ID: NCT07006792

This clinical trial is investigating how well a medication called lebrikizumab works for adults and teenagers with moderate atopic dermatitis, commonly known as eczema, who experience a lot of itch...

Recruiting

Phase: PHASE4 Conditions: Atopic Dermatitis

Safety Study in Subjects ≥ 12 Years of Age With Hereditary Angioedema Switching to Garadacimab

NCT ID: NCT06806657

This clinical trial is looking at the safety of a new treatment called garadacimab for people aged 12 and older who have hereditary angioedema (HAE). The study aims to see how well patients do afte...

Recruiting

Phase: PHASE4 Conditions: Hereditary Angioedema

Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

NCT ID: NCT05769777

This clinical trial is looking at a new treatment called amlitelimab for people aged 12 and older who have moderate to severe atopic dermatitis, also known as eczema. The goal is to see how safe an...

Recruiting

Phase: PHASE2 Conditions: Dermatitis Atopic

A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)

NCT ID: NCT06455202

This clinical trial is studying a new treatment called barzolvolimab for adults suffering from Chronic Spontaneous Urticaria (CSU), which is a condition where people experience itchy hives without ...

Recruiting

Phase: PHASE3 Conditions: Chronic Spontaneous Urticaria

ABTECT - Maintenance

NCT ID: NCT05535946

The ABTECT - Maintenance clinical trial is studying a new medication called ABX464, which is being tested to see how well it works as a long-term treatment for people with moderately to severely ac...

Recruiting

Phase: PHASE3 Conditions: Ulcerative Colitis

ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2

NCT ID: NCT05507216

The ABTECT-2 clinical trial is investigating a new treatment called ABX464 for patients suffering from moderately to severely active ulcerative colitis, a condition that causes inflammation in the ...

Recruiting

Phase: PHASE3 Conditions: Ulcerative Colitis